hepatocellular carcinoma
Conditions
Interventions
TACE group:N/A
Liver resection group:N/A
Sponsors
Air Force Military Medical University Tangdu Hospital; Daping Hospital, Army Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 91 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1) Study subjects were diagnosed with primary liver cancer; 2) study subjects were treated with hepatic resection or hepatic artery embolization chemotherapy; 3)study subjects with detailed clinical letters, including tumor size and tumor number; 4) good liver function with a Child Pugh score less than or equal to 7; 5) The study subject had an ECOG-PS score of 0-1.
Exclusion criteria
Exclusion criteria: 1) intrahepatic, extrahepatic metastases or vascular invasion; 2) Study subjects with uncontrolled decompensated cirrhosis, including acute upper gastrointestinal bleeding, ascites, hepatic encephalopathy; 3)study subjects with other systemic primary tumors; 4)follow-up period of less than 1 month; 5)Age less than 18 years.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| tumor size;tumor number;AFP;AST;ALT;platelet;white blood cell; | — |
Countries
China
Contacts
Public Contactliu lei
Air Force Military Medical University Tangdu Hospital;Daping Hospital,, Army Medical University
Outcome results
None listed